Evidence map›Paper›PMID 24747690›Full record

ArticleBiochimica et biophysica acta2014

Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling.

Marianna Penzo, David M Habiel, Mahalakshmi Ramadass, Richard R Kew, Kenneth B Marcu

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Oxidative medicine and cellular longevity · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-κB Predicts Poor Prognosis in Cervical Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marianna PenzoCRBA Laboratory and Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
David M HabielMolecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY, 11794 USA.
Mahalakshmi RamadassMolecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY, 11794 USA.
Richard R Kew *Molecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY, 11794 USA.
Kenneth B Marcu *Biochemistry and Cell Biology Dept., Stony Brook University, Stony Brook, New York 11794-5215, USA.
Stony Brook University Hospital · USStony Brook University · US

Funding

Mechanisms of a Novel Chemotactic Cofactor for C5aR01GM063769 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI KEW, RICHARD R · 2001 to 2011
$2.6M
MOLECULAR AND CELLULAR BIOLOGY TRAINING PROGRAMT32GM008468 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 1997 to 2016
$1.9M
Novel roles of IKK complex to program gene expressionR01GM066882 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MARCU, KENNETH B · 2003 to 2006
$1.3M
Mechanisms of a Novel Chemotactic Cofactor for C5aR56GM063769 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI KEW, RICHARD R · 2007 to 2007
$310k
NIGMS NIH HHS 5T32 GM008468NIGMS NIH HHS GM063769NIGMS NIH HHS GM066882NIGMS NIH HHS R01 GM063769NIGMS NIH HHS R01 GM066882NIGMS NIH HHS R56 GM063769NIGMS NIH HHS T32 GM008468
6 · The paper itself

Abstract

CXCL12 and its unique receptor CXCR4, is critical for the homing of a variety of cell lineages during both development and tissue repair. CXCL12 is particularly important for the recruitment of hemato/lymphopoietic cells to their target organs. In conjunction with the damage-associated alarmin molecule HMGB1, CXCL12 mediates immune effector and stem/progenitor cell migration towards damaged tissues for subsequent repair. Previously, we showed that cell migration to HMGB1 simultaneously requires both IKKβ and IKKα-dependent NF-κB activation. IKKβ-mediated activation maintains sufficient expression of HMGB1's receptor RAGE, while IKKα-dependent NF-κB activation ensures continuous production of CXCL12, which complexes with HMGB1 to engage CXCR4. Here using fibroblasts and primary mature macrophages, we show that IKKβ and IKKα are simultaneously essential for cell migration in response to CXCL12 alone. Non-canonical NF-κB pathway subunits RelB and p52 are also both essential for cell migration towards CXCL12, suggesting that IKKα is required to drive non-canonical NF-κB signaling. Flow cytometric analyses of CXCR4 expression show that IKKβ, but not IKKα, is required to maintain a critical threshold level of this CXCL12 receptor. Time-lapse video microscopy experiments in primary MEFs reveal that IKKα is required both for polarization of cells towards a CXCL12 gradient and to establish a basal level of velocity towards CXCL12. In addition, CXCL12 modestly up-regulates IKKα-dependent p52 nuclear translocation and IKKα-dependent expression of the CXCL12 gene. On the basis of our collective results we posit that IKKα is needed to maintain the basal expression of a critical protein co-factor required for cell migration to CXCL12.

Indexed as

AnimalsCell MovementCell NucleusChemokine CXCL12FibroblastsHumansI-kappa B KinaseMacrophagesMiceMice, KnockoutNF-kappa BReceptors, CXCR4RNA, MessengerSignal TransductionTranscription Factor RelAUp-RegulationChemokine CXCL12Chuk protein, mouseCXCR4 protein, mouseI-kappa B KinaseIkbkb protein, mouseNF-kappa BReceptors, CXCR4RNA, MessengerTranscription Factor RelACell migrationCXCL12CXCR4IKKαIKKβNF-κB

Identifiers

PMID24747690
PMCPMC4096130
OpenAlexW2013562385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.